COPD Management: 7 Best Anoro Ellipta Alternatives

COPD or Chronic Obstructive Pulmonary Disease is a lung disorder that affects millions of individuals worldwide. The well-known drug Anoro Ellipta is used to treat COPD. The combination inhaler Anoro Ellipta contains two distinct types of medications: LABA (Long-Acting Beta Agonist) and LAMA (Long-Acting Muscarinic Antagonist). In order to make breathing easier, these two drugs work together to open up the airways.

Despite this drug’s great effectiveness, some people might want to look into other options. Changes may be made for a variety of reasons, such as concerns about costs, adverse health effects, or just a desire to better suit their lifestyle. This article’s goal is to provide more options that can help with COPD management. Remember that it’s important to speak with your doctor before making any changes to your prescription.

Understanding COPD Medication Classes

Chronic obstructive pulmonary disease (COPD) requires specific pharmaceutical management. An outline of the main types of COPD medications is provided below; they are all designed to improve lung function, lessen exacerbations, and alleviate symptoms.

 

Long-Acting Beta Agonists (LABAs)

For many patients, the combination of LABAs and LAMAs in a single inhaler can increase the efficacy of treatment. Combination treatments like Anoro Ellipta and Stiolto Respimat combine LABAs and LAMAs to provide a dual strategy for addressing mucus secretion and airway constriction.

Compared to utilizing only one medication, research indicates that a mix of medicines can lead to better symptom control, a lower risk of exacerbations, and improved lung function. Patients who experience severe symptoms or frequent exacerbations will benefit most from this approach.

 

Long-Acting Muscarinic Antagonists (LAMAs)

Long-acting muscarinic antagonists, or LAMAs, are bronchodilators that are well-known for their capacity to reduce mucus production and avoid airway constriction. These medications, such as tiotropium and umeclidinium, work by blocking muscarinic receptors, which reduces the risk of airway constriction and facilitates the removal of mucus. Like LABAs, LAMAs provide long-lasting assistance and are typically given once daily.

Because LAMAs are effective at treating both mucus buildup and airway constriction, they are frequently suggested as the first line of treatment for people with moderate to severe COPD. According to studies, LAMAs may improve quality of life and reduce hospital visits by reducing the frequency of COPD exacerbations.

 

Combination Therapies (LABA/LAMA)

For many patients, the combination of LABAs and LAMAs in a single inhaler can increase the efficacy of treatment. Combination treatments like Anoro Ellipta and Stiolto Respimat combine LABAs and LAMAs to provide a dual strategy for addressing mucus secretion and airway constriction.

Compared to utilizing only one medication, research indicates that a mix of medicines can lead to better symptom control, a lower risk of exacerbations, and improved lung function. Patients who experience severe symptoms or frequent exacerbations will benefit most from this approach.

 

Inhaled Corticosteroids (ICS)

Flare-ups can be avoided by using inhaled corticosteroids, or ICS, which reduce airway inflammation. ICS drugs are indicated for COPD patients, especially those who experience repeated exacerbations, even though they are more commonly used for asthma. Common ICS drugs used to treat COPD include fluticasone and budesonide.

For high-risk patients who are prone to exacerbations, LABAs are frequently used with ICS medicines. However, they may increase the risk of pneumonia in people with COPD, which is why they are typically only recommended for those with the worst symptoms.

 

Phosphodiesterase-4 Inhibitors (PDE4 Inhibitors)

PDE4 inhibitors, such roflumilast, are an additional option for patients with severe COPD and chronic bronchitis. With an emphasis on the lungs, this oral medicine lowers inflammation throughout the body. PDE4 inhibitors help patients with recurrent flare-ups experience fewer exacerbations.

These medications are usually only used after other treatments have failed due to the possibility of adverse effects like nausea and weight loss..

 

Short-Acting Bronchodilators (SABAs and SAMAs)

For acute symptoms like wheezing or dyspnea, quickly-relieving bronchodilators such as short-acting muscarinic antagonists (SAMAs) and short-acting beta agonists (SABAs) provide immediate relief. Quick-relief inhalers frequently contain medications that provide immediate relief, such as ipratropium (a short-acting muscarinic antagonist) and albuterol (a short-acting beta agonist). These drugs can help manage acute symptoms or deteriorating diseases, but they are not intended for long-term usage.

 

Delivery Forms of COPD Medications

Various COPD medicine delivery techniques guarantee direct lung administration, resulting in prompt symptom alleviation:

Breathing devices: This is like dry powder inhalers (DPIs) and metered-dose inhalers (MDIs), which are portable and offer a practical means of delivering medication directly into the lungs. They are the most often used kind of COPD medicine.

Nebulisers: This transforms medication into a thin mist, making it easier for people with severe symptoms to inhale larger amounts. They are especially helpful for those who have trouble using inhalers due to poor or reduced lung function.

Oral drugs: Although they are not as commonly utilized, some medications, such PDE4 inhibitors, are consumed to manage symptoms.

 

The Importance of the Right Medication and Delivery Method

For COPD symptoms to be effectively managed, the right medicine and delivery mechanism must be chosen. People with COPD can improve lung capacity, manage symptoms better, and experience fewer exacerbations by following a personalized treatment plan. People can successfully manage their disease with regular use of the right drugs, which will increase their level of activity and improve their general quality of life. 

Working together with a healthcare professional to assess symptoms and discuss possible side effects can help tailor treatment to each patient’s unique needs.  

The 7 Alternatives

Stiolto Respimat  

 

Symbicort  

 

Advair  

 

Breo Ellipta  

 

Dulera  

 

Bevespi Aerosphere  

 

Trelegy Ellipta  

Comparison Factors

 

Special Considerations

Different people respond differently to COPD drugs, and some characteristics that may influence your choice are as follows:

Making the Switch

Here are some actions to take if you’re thinking about switching from this drug to another option:

 

Conclusion

In order to manage symptoms, improve quality of life, and preserve lung health, choosing the appropriate COPD treatment is essential. Consult a healthcare provider about the alternatives listed below if you or someone you care about has COPD and is considering making a change. Trying an alternative drug could make a big difference. Explore options for these drugs and learn about cost-saving initiatives that can help reduce the cost of your care by using our online pharmacy referral service.

3665sc.on-forge.com/ is an established pharmacy referral service. Order brand name and generic equivalent drugs online from a trusted Canadian drug source. Log onto www.365scriptcare.com to see how you can buy discounted drug prices shipped to the USA from Canada.